MX2009011638A - Composiciones basadas en gp5 de prrsv y metodos. - Google Patents

Composiciones basadas en gp5 de prrsv y metodos.

Info

Publication number
MX2009011638A
MX2009011638A MX2009011638A MX2009011638A MX2009011638A MX 2009011638 A MX2009011638 A MX 2009011638A MX 2009011638 A MX2009011638 A MX 2009011638A MX 2009011638 A MX2009011638 A MX 2009011638A MX 2009011638 A MX2009011638 A MX 2009011638A
Authority
MX
Mexico
Prior art keywords
prrsv
vaccins
proteins
methods
domains
Prior art date
Application number
MX2009011638A
Other languages
English (en)
Inventor
Byong-Kwan Kim
Original Assignee
Mj Biolog Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mj Biolog Inc filed Critical Mj Biolog Inc
Publication of MX2009011638A publication Critical patent/MX2009011638A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10071—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La descripción incluye composiciones y métodos para la producción de una respuesta inmune contra el virus de síndrome reproductor y respiratorio porcino ((PRRS), o PRRSV. La descripción está basada en parte sobre el uso de dos o más dominios de péptido, cada uno con una secuencia diferente, del ectodominio de proteína GP5 de PRRSV. Se describen composiciones y métodos que comprenden polipéptidos que contienen los dos o más dominios, o ácidos nucleicos que los codifican.
MX2009011638A 2007-04-30 2008-04-30 Composiciones basadas en gp5 de prrsv y metodos. MX2009011638A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91504907P 2007-04-30 2007-04-30
PCT/US2008/061962 WO2008134697A2 (en) 2007-04-30 2008-04-30 Prrsv vaccins based on gp5 proteins

Publications (1)

Publication Number Publication Date
MX2009011638A true MX2009011638A (es) 2010-03-26

Family

ID=39926318

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009011638A MX2009011638A (es) 2007-04-30 2008-04-30 Composiciones basadas en gp5 de prrsv y metodos.

Country Status (13)

Country Link
US (3) US8142788B2 (es)
EP (2) EP2508203A1 (es)
JP (1) JP2010526086A (es)
KR (1) KR101673883B1 (es)
CN (1) CN101578112A (es)
CA (1) CA2685170C (es)
DK (1) DK2152306T3 (es)
ES (1) ES2526406T3 (es)
HK (1) HK1140969A1 (es)
MX (1) MX2009011638A (es)
PL (1) PL2152306T3 (es)
TW (2) TW201605471A (es)
WO (1) WO2008134697A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201605471A (zh) * 2007-04-30 2016-02-16 Ｍｊ生物股份有限公司 豬繁殖與呼吸道症候群病毒（ｐｒｒｓｖ）ｇｐ５爲主之組成物及方法
WO2011153351A2 (en) * 2010-06-02 2011-12-08 Virginia Tech Intellectual Properties, Inc. Novel modified live-attenuated vaccines (mlv) and subunit vaccines created by dna shuffling against porcine reproductive and respiratory syndrome virus (prrsv)
CA2859944C (en) * 2011-12-30 2023-01-24 United Biomedical, Inc. Synthetic peptide-based marker vaccine and diagnostic system for effective control of porcine reproductive and respiratory syndrome (prrs)
CN104302316A (zh) * 2012-05-17 2015-01-21 佐蒂斯有限责任公司 在断奶之前对抗猪繁殖与呼吸综合征(prrs)病毒的有效疫苗接种
CN102796181A (zh) * 2012-06-20 2012-11-28 韩健宝 猪繁殖与呼吸综合征病毒的肽核酸及其应用
ES2682084T3 (es) 2014-02-07 2018-09-18 Mj Biologics, Inc. Proteínas y antígenos del virus de la diarrea epidémica porcina (VDEP)
US10280199B2 (en) 2014-02-07 2019-05-07 Phibro Animal Health Corporation Coronavirus proteins and antigens
WO2016130569A1 (en) 2015-02-09 2016-08-18 Mj Biologics, Inc. A composition comprising pedv antigens and methods for making and using the composition
CA2957513A1 (en) * 2014-08-08 2016-02-11 Idemitsu Kosan Co., Ltd. Agent for controlling porcine reproductive and respiratory syndrome
MX2017016895A (es) * 2015-06-23 2018-04-10 Merial Inc Vectores virales recombinantes que contienen la proteina menor del virus del sindrome reproductor y respiratorio porcino (prrsv) y sus metodos de elaboracion y uso.
HRP20240344T1 (hr) 2017-06-02 2024-05-24 Ambrx, Inc. Postupci i pripravci za unapređenje produkcije proteina koji sadrže neprirodne aminokiseline
CN115785286B (zh) * 2022-12-05 2023-07-14 北京标驰泽惠生物科技有限公司 一种猪繁殖与呼吸综合征病毒的融合蛋白及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1156111A1 (en) 2000-05-19 2001-11-21 Stichting Dienst Landbouwkundig Onderzoek Chimeric arterivirus-like particles
CA2620667A1 (en) * 2005-08-30 2007-04-12 Board Of Regents Of The University Of Nebraska Methods and compositions for vaccination of animals with prrsv antigens with improved immunogenicity
WO2007064742A2 (en) * 2005-11-29 2007-06-07 Iowa State University Research Foundation, Inc. Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (prrsv) and uses thereof
TW201605471A (zh) * 2007-04-30 2016-02-16 Ｍｊ生物股份有限公司 豬繁殖與呼吸道症候群病毒（ｐｒｒｓｖ）ｇｐ５爲主之組成物及方法

Also Published As

Publication number Publication date
PL2152306T3 (pl) 2015-07-31
US20090208520A1 (en) 2009-08-20
TW201605471A (zh) 2016-02-16
HK1140969A1 (en) 2010-10-29
CA2685170A1 (en) 2008-11-06
US20120141978A1 (en) 2012-06-07
JP2010526086A (ja) 2010-07-29
EP2508203A1 (en) 2012-10-10
CA2685170C (en) 2017-03-28
KR20100017504A (ko) 2010-02-16
WO2008134697A2 (en) 2008-11-06
US8142788B2 (en) 2012-03-27
KR101673883B1 (ko) 2016-11-08
EP2152306A2 (en) 2010-02-17
DK2152306T3 (en) 2014-12-08
ES2526406T3 (es) 2015-01-12
CN101578112A (zh) 2009-11-11
US20160256536A1 (en) 2016-09-08
EP2152306B1 (en) 2014-11-26
WO2008134697A3 (en) 2009-02-12
TW200914043A (en) 2009-04-01

Similar Documents

Publication Publication Date Title
MX2009011638A (es) Composiciones basadas en gp5 de prrsv y metodos.
MXPA03009354A (es) Un clon infeccioso de adnc del virus del sindrome reproductivo y respiratorio porcino (prrs) norteamericano y sus usos.
MX2007007586A (es) Composiciones de proteinas de virus de gripe y metodos de uso de las mismas.
WO2003106684A3 (en) PROCESS FOR THE SIMULTANEOUS PRODUCTION OF SEVERAL PROTEINS; VECTORS AND CELLS USED IN THIS PROCESS
DE60330767D1 (de) Ferritinfusionsproteine zur verwendung für impfstoffe und andere anwendungen
MX2022002051A (es) Fuentes de proteina de origen no animal con propiedades funcionales.
GEP20135967B (en) Improved reconstituted surfactant composition containing surfactant protein b (sp-b), and surfactant protein c (sp-c) analogs
WO2010074575A3 (en) Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv.
WO2006083301A3 (en) Immunogenic compositions comprising hmgb1 polypeptides
PL1951882T3 (pl) Kwasy nukleinowe kodujące szczepionkę przeciwko wirusowi wywołującemu zespół zaburzeń reprodukcyjnych i oddechowych u świń
WO2007130455A3 (en) Compositions and methods for treatment of non-hodgkins lymphoma
MX2007010220A (es) Peptidos para la deteccion de anticuerpo para el virus del sindrome respiratorio reproductivo porcino.
WO2007053188A3 (en) Production of multivalent virus like particles
NZ610376A (en) North american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
UA98620C2 (uk) Атенуйований вірус класичної лихоманки свиней, що містить модифікований глікопротеїн е2
MX2009012326A (es) Peptidos de señalizacion.
CA2409209A1 (en) Chimeric arterivirus-like particles
AR095482A1 (es) Virus del síndrome reproductivo y respiratorio porcino, composiciones, vacuna y métodos de uso
UA107180C2 (uk) Туберкульозний білок rv1753c, композиція, що його містить, та застосування
NZ609916A (en) Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
NZ596501A (en) Casb7439 constructs
MY157396A (en) Novel fusion proteins and use thereof for preparing hepatitis c vaccines
ATE466874T1 (de) Mit scytovirin der domäne 1 verwandte polypeptide
WO2007058267A8 (ja) 新規タンパク質及びそれをコードする遺伝子
WO2007127372A3 (en) Genetic adjuvants for viral vaccines

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration